1-76868635-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_030965.3(ST6GALNAC5):c.154G>A(p.Ala52Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030965.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST6GALNAC5 | NM_030965.3 | c.154G>A | p.Ala52Thr | missense_variant | Exon 2 of 5 | ENST00000477717.6 | NP_112227.1 | |
ST6GALNAC5 | NM_001320273.2 | c.154G>A | p.Ala52Thr | missense_variant | Exon 2 of 4 | NP_001307202.1 | ||
ST6GALNAC5 | NM_001320274.2 | c.154G>A | p.Ala52Thr | missense_variant | Exon 2 of 3 | NP_001307203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST6GALNAC5 | ENST00000477717.6 | c.154G>A | p.Ala52Thr | missense_variant | Exon 2 of 5 | 1 | NM_030965.3 | ENSP00000417583.1 | ||
ST6GALNAC5 | ENST00000318803.6 | n.154G>A | non_coding_transcript_exon_variant | Exon 2 of 5 | 5 | ENSP00000436263.1 | ||||
ST6GALNAC5 | ENST00000480428.1 | n.350G>A | non_coding_transcript_exon_variant | Exon 2 of 3 | 4 | |||||
ST6GALNAC5 | ENST00000496845.1 | n.348G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.154G>A (p.A52T) alteration is located in exon 2 (coding exon 2) of the ST6GALNAC5 gene. This alteration results from a G to A substitution at nucleotide position 154, causing the alanine (A) at amino acid position 52 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at